Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
Start Date
5/19/2026
Completion Date
6/15/2028
Summary
This is a single center 2-phase study to assess effects of using text messages on adherence to oral chemotherapy for patients with acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma.
Detailed Description
The study will begin with a 28-day pilot phase where participants will be asked to complete questionnaires to determine if the text message intervention is acceptable to participants. In the efficacy phase, the study will compare adherence to oral mercaptopurine and methotrexate between those who receive the high intensity text message intervention and those who receive standard-of-care. It is believed that high-intensity text messages will increase patient adherence within cycle 1.
Eligibility Criteria
Age Range: 15 years to No maximum
Interventions
High Intensity
No Text Messagings
Low Intensity Text Messaging
Conditions
Locations
University of Chicago Medicine Comprehensive Cancer Center
Chicago, Illinois 60637
United States